235 related articles for article (PubMed ID: 33927297)
41. Serum (1-3)-beta-D-glucan as a tool for diagnosis of Pneumocystis jirovecii pneumonia in patients with human immunodeficiency virus infection or hematological malignancy.
Desmet S; Van Wijngaerden E; Maertens J; Verhaegen J; Verbeken E; De Munter P; Meersseman W; Van Meensel B; Van Eldere J; Lagrou K
J Clin Microbiol; 2009 Dec; 47(12):3871-4. PubMed ID: 19846641
[TBL] [Abstract][Full Text] [Related]
42. Performances of Four Real-Time PCR Assays for Diagnosis of Pneumocystis jirovecii Pneumonia.
Sasso M; Chastang-Dumas E; Bastide S; Alonso S; Lechiche C; Bourgeois N; Lachaud L
J Clin Microbiol; 2016 Mar; 54(3):625-30. PubMed ID: 26719435
[TBL] [Abstract][Full Text] [Related]
43. Serum (1,3)-Beta-d-Glucan has suboptimal performance for the diagnosis of Pneumocystis jirovecii pneumonia in cancer patients and correlates poorly with respiratory burden as measured by quantitative PCR.
Szvalb AD; Malek AE; Jiang Y; Bhatti MM; Wurster S; Kontoyiannis DP
J Infect; 2020 Sep; 81(3):443-451. PubMed ID: 32650108
[TBL] [Abstract][Full Text] [Related]
44. Prevalence of Pneumocystis jirovecii pneumonia (2010-2013): the first Croatian report.
Babic-Erceg A; Vilibic-Cavlek T; Erceg M; Mlinaric-Missoni E; Begovac J
Acta Microbiol Immunol Hung; 2014 Jun; 61(2):181-8. PubMed ID: 24939686
[TBL] [Abstract][Full Text] [Related]
45. Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia.
Salzer HJF; Schäfer G; Hoenigl M; Günther G; Hoffmann C; Kalsdorf B; Alanio A; Lange C
Respiration; 2018; 96(1):52-65. PubMed ID: 29635251
[TBL] [Abstract][Full Text] [Related]
46. Pneumocystis jirovecii pneumonia (PCP) PCR-negative conversion predicts prognosis of HIV-negative patients with PCP and acute respiratory failure.
Choi JS; Lee SH; Leem AY; Song JH; Kim SY; Chung KS; Jung JY; Kang YA; Kim YS; Chang J; Park MS
PLoS One; 2018; 13(10):e0206231. PubMed ID: 30359436
[TBL] [Abstract][Full Text] [Related]
47. A Negative (1,3)-β-D-Glucan Result Alone Is Not Sufficient to Rule Out a Diagnosis of
Damiani C; Demey B; Pauc C; Le Govic Y; Totet A
Front Microbiol; 2021; 12():713265. PubMed ID: 34456893
[No Abstract] [Full Text] [Related]
48. Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.
Robert-Gangneux F; Belaz S; Revest M; Tattevin P; Jouneau S; Decaux O; Chevrier S; Le Tulzo Y; Gangneux JP
J Clin Microbiol; 2014 Sep; 52(9):3370-6. PubMed ID: 25009050
[TBL] [Abstract][Full Text] [Related]
49. Performance of the RealStar
Salsé M; Mercier V; Carles MJ; Lechiche C; Sasso M
Mycoses; 2021 Oct; 64(10):1230-1237. PubMed ID: 34346113
[TBL] [Abstract][Full Text] [Related]
50. Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveolar lavage fluid of HIV-infected patients.
Huggett JF; Taylor MS; Kocjan G; Evans HE; Morris-Jones S; Gant V; Novak T; Costello AM; Zumla A; Miller RF
Thorax; 2008 Feb; 63(2):154-9. PubMed ID: 17693588
[TBL] [Abstract][Full Text] [Related]
51. Comparison of different microbiological procedures for the diagnosis of Pneumocystis jirovecii pneumonia on bronchoalveolar-lavage fluid.
Franconi I; Leonildi A; Erra G; Fais R; Falcone M; Ghelardi E; Lupetti A
BMC Microbiol; 2022 May; 22(1):143. PubMed ID: 35597925
[TBL] [Abstract][Full Text] [Related]
52. A highly sensitive novel PCR assay for detection of Pneumocystis jirovecii DNA in bronchoalveloar lavage specimens from immunocompromised patients.
Tia T; Putaporntip C; Kosuwin R; Kongpolprom N; Kawkitinarong K; Jongwutiwes S
Clin Microbiol Infect; 2012 Jun; 18(6):598-603. PubMed ID: 21951463
[TBL] [Abstract][Full Text] [Related]
53. Utility of lactate dehydrogenase vs radiographic severity in the differential diagnosis of Pneumocystis carinii pneumonia.
Boldt MJ; Bai TR
Chest; 1997 May; 111(5):1187-92. PubMed ID: 9149568
[TBL] [Abstract][Full Text] [Related]
54. Serial change in serum biomarkers during treatment of Non-HIV Pneumocystis pneumonia.
Urabe N; Sakamoto S; Sano G; Ito A; Sekiguchi R; Homma S
J Infect Chemother; 2019 Dec; 25(12):936-942. PubMed ID: 31186197
[TBL] [Abstract][Full Text] [Related]
55. Development of a fully automated PCR assay for the detection of Pneumocystis jirovecii using the GENECUBE system.
Matsumura Y; Tsuchido Y; Yamamoto M; Nakano S; Nagao M
Med Mycol; 2019 Oct; 57(7):841-847. PubMed ID: 30590702
[TBL] [Abstract][Full Text] [Related]
56. Diagnosis and treatment of Pneumocystis jirovecii pneumonia in HIV-infected or non-HIV-infected patients-difficulties in diagnosis and adverse effects of trimethoprim-sulfamethoxazole.
Kato H; Samukawa S; Takahashi H; Nakajima H
J Infect Chemother; 2019 Nov; 25(11):920-924. PubMed ID: 31300379
[TBL] [Abstract][Full Text] [Related]
57. Role of Serum (1,3)-Β-D-Glucan to Screen for Pneumocystis Pneumonia in Kidney Transplant Recipients.
Tandukar S; Singh N; Naseer MS; Chand R; Brunet H; Shokouh-Amiri HM
Transplant Proc; 2021 Apr; 53(3):1075-1079. PubMed ID: 32928557
[TBL] [Abstract][Full Text] [Related]
58. Non-invasive diagnosis of Pneumocystis jirovecii pneumonia: a systematic review and meta-analysis.
Senécal J; Smyth E; Del Corpo O; Hsu JM; Amar-Zifkin A; Bergeron A; Cheng MP; Butler-Laporte G; McDonald EG; Lee TC
Clin Microbiol Infect; 2022 Jan; 28(1):23-30. PubMed ID: 34464734
[TBL] [Abstract][Full Text] [Related]
59. [Value of the LDH level in pneumocystis carinii pneumonia in patients infected with human immunodeficiency virus].
Boudes P; Furhman C; Verra F; Sobel A
Ann Med Interne (Paris); 1990; 141(2):175-8. PubMed ID: 2353759
[TBL] [Abstract][Full Text] [Related]
60. Elevated serum lactate dehydrogenase aids prediction of mortality in Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection - Derivation of a clinical risk score.
Koh MCY; Ngiam JN; Tambyah PA; Lum LH
J Infect Public Health; 2024 Jul; 17(7):102439. PubMed ID: 38820900
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
